Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

7,807 total articles

Texas Wealth Solutions Joins LPL’s Independent Advisor Network

Texas Wealth Solutions Joins LPL’s Independent Advisor Network

LPL Financial announced that Brian Bogue has launched Texas Wealth Solutions by affiliating with LPL's Independent Advisor Network. Bogue brings approximately $235 million in assets under management and over 25 years of experience, focusing on serving pre-retirees and retirees in East Texas. This move enables him to operate independently while leve…

Carriage Services Declares Quarterly Cash Dividend

Carriage Services Declares Quarterly Cash Dividend

Carriage Services, Inc., a US-based provider of funeral and cemetery services, announced a quarterly cash dividend of 11.25 cents per share, payable June 1, 2026, to shareholders of record May 4, 2026. The company operates 155 funeral homes and 28 cemeteries across multiple states, emphasizing innovation and elevated service.

DSS, Inc. Letter to Shareholders

DSS, Inc. Letter to Shareholders

DSS, Inc. announces substantial operational progress in 2025, including a 43% reduction in costs and expenses, enhanced financial discipline, and strategic realignment into four core business segments. The company highlights growth in Product Packaging and Securities & Investment Management, completed the spin-out of Impact BioMedical, and plans a …

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial

PDS Biotechnology announced encouraging interim Phase 2 clinical trial results for its tumor-targeted IL-12 immunocytokine, PDS01ADC, in patients with metastatic colorectal cancer (mCRC) with liver metastases. The trial showed a 78% objective response rate and over 80% two-year survival, significantly outperforming parallel studies without PDS01ADC…

XMax Inc. Announces Fiscal Year 2025 Financial Results

XMax Inc. Announces Fiscal Year 2025 Financial Results

XMax Inc. announced a 73% increase in net sales for fiscal year 2025, driven by its furniture business, while also embarking on a new strategic expansion into artificial intelligence technologies. The company established a subsidiary, XMax AI Inc., and partnered to build a cloud-based AI platform on AWS, signaling diversification of revenue streams…

Allbirds, Inc. Executes $50M Convertible Financing Facility Agreement; Announces Expansion into AI Compute Infrastructure

Allbirds, Inc. Executes $50M Convertible Financing Facility Agreement; Announces Expansion into AI Compute Infrastructure

Allbirds, Inc. announced a $50 million convertible financing facility to fund its strategic pivot from footwear to AI compute infrastructure. Following the sale of its brand and footwear assets to American Exchange Group, the company plans to become NewBird AI, a GPU-as-a-Service and AI-native cloud provider targeting the unmet demand for high-perf…

NOV Provides Operational Update for First Quarter 2026

NOV Provides Operational Update for First Quarter 2026

NOV Inc. announced that operational disruptions caused by the Middle East conflict have led to lower than expected first quarter 2026 revenues and earnings. The company now expects $2.05 billion in revenue, $47 million in operating profit, and $177 million in Adjusted EBITDA, impacted by estimated $54 million revenue and $32 million EBITDA losses d…

Calidi Biotherapeutics Announces Participation in RedChip’s April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms

Calidi Biotherapeutics Announces Participation in RedChip’s April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms

Calidi Biotherapeutics (NYSE American: CLDI) announced its participation in RedChip's virtual investor conference on April 16, 2026, focusing on its innovative RedTail platform for targeted genetic medicines. The company highlighted the upcoming IND filing for CLD-401, its lead candidate targeting solid tumors using systemic virotherapy, and discus…

Vivos Therapeutics Reports Full Year 2025 Financial Results

Vivos Therapeutics Reports Full Year 2025 Financial Results

Vivos Therapeutics, Inc. announced its full year 2025 financial results highlighting a 16% increase in revenue to $17.5 million driven by the integration of The Sleep Center of Nevada and expanded sleep testing services. Despite gross margin stability at 60%, operating expenses significantly increased due to integration costs, leading to a larger o…

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners

Teva Launches Home Ground™ Schizophrenia Community, a New Online Resource Hub for People Living with Schizophrenia and Their Care Partners

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) has launched Home Ground™ Schizophrenia Community, an online platform offering peer-driven resources, tools, and support for people living with schizophrenia and their care partners. Developed collaboratively with patients, caregivers, and advocacy groups, the platform aims to reduce isolation by pro…

Wintrust Financial Corporation Announces Cash Dividends

Wintrust Financial Corporation Announces Cash Dividends

Wintrust Financial Corporation's Board of Directors has approved a quarterly cash dividend of $0.55 per share on its common stock, payable May 28, 2026, and a cash dividend on its Series F preferred stock, payable July 15, 2026. The company operates multiple community banks and financial services across several Midwest and Florida regions, with tot…

Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat

Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat

Tango Therapeutics, a clinical-stage biotech company listed on NASDAQ, announced key leadership appointments including a new CFO, Chief Development Operations Officer, and SVP of Corporate Strategy. These changes aim to support the accelerated advancement and potential regulatory approval of their PRMT5 inhibitor, vopimetostat, for pancreatic cance…

Zoom appoints Russell Dicker as chief product officer to advance AI-first product strategy and workflow automation

Zoom appoints Russell Dicker as chief product officer to advance AI-first product strategy and workflow automation

Zoom Communications appoints Russell Dicker as Chief Product Officer to lead its AI-driven product strategy and advance workflow automation. Dicker's extensive experience at Microsoft Teams, Google Maps, and Amazon positions him to accelerate Zoom's vision of integrating AI across its platform to transform how people connect and collaborate, enabli…

PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples

PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples

PacBio and Covaris have developed a collaborative workflow combining Covaris’ truXTRAC FFPE extraction technology and PacBio’s Kinnex library preparation and Revio sequencing systems. This innovation enables robust, high-quality HiFi long-read sequencing from formalin-fixed, paraffin-embedded (FFPE) tumor samples, overcoming historic challenges due…

Toro Corp. Reports Net Income of $1.6 Million for the Three Months Ended December 31, 2025 and $5.9 Million for the Year Ended December 31, 2025

Toro Corp. Reports Net Income of $1.6 Million for the Three Months Ended December 31, 2025 and $5.9 Million for the Year Ended December 31, 2025

Toro Corp., a NASDAQ-listed global energy transportation provider, announced its financial results for Q4 and the full year 2025. The company reported a 60% increase in net income to $1.6 million in Q4 driven by higher vessel revenues and daily charter rates, despite a 5.8% decrease in full-year vessel revenues. Cash position improved substantially…